foxo4 dri senolytic peptide human trial 2024 2025 Buy FOXO4-DRI (Proxofim) - 10mg The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Senolytic Interventions for Type 2 Diabetes: Current Evidence and Future Directions
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




